» Articles » PMID: 24030068

Alternative Splicing and Differential Expression of the Islet Autoantigen IGRP Between Pancreas and Thymus Contributes to Immunogenicity of Pancreatic Islets but Not Diabetogenicity in Humans

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2013 Sep 14
PMID 24030068
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Thymic expression of self-antigens during T-lymphocyte development is believed to be crucial for preventing autoimmunity. It has been suggested that G6PC2, the gene encoding islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), is differentially spliced between pancreatic beta cells and the thymus. This may contribute to incomplete elimination of IGRP-specific T lymphocytes in the thymus, predisposing individuals to type 1 diabetes. We tested whether specific splice variation in islets vs thymus correlates with loss of tolerance to IGRP in type 1 diabetes.

Methods: Expression of G6PC2 splice variants was compared among thymus, purified medullary thymic epithelial cells and pancreatic islets by RT-PCR. Differential immunogenicity of IGRP splice variants was tested in patients and healthy individuals for autoantibodies and specific cytotoxic T lymphocytes using radiobinding assays and HLA class I multimers, respectively.

Results: Previously reported G6PC2 splice variants, including full-length G6PC2, were confirmed, albeit that they occurred in both pancreas and thymus, rather than islets alone. Yet, their expression levels were profoundly greater in islets than in thymus. Moreover, three novel G6PC2 variants were discovered that occur in islets only, leading to protein truncations, frame shifts and neo-sequences prone to immunogenicity. However, autoantibodies to novel or known IGRP splice variants did not differ between patients and healthy individuals, and similar frequencies of IGRP-specific cytotoxic T lymphocytes could be detected in both patients with type 1 diabetes and healthy individuals.

Conclusions/interpretation: We propose that post-transcriptional variation of tissue-specific self-proteins may affect negative thymic selection, although this need not necessarily lead to disease.

Citing Articles

Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation.

Garcia J, Tayo L Genes (Basel). 2024; 15(4).

PMID: 38674328 PMC: 11049615. DOI: 10.3390/genes15040393.


Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.

Fuchs K, van de Meent M, Honders M, Khatri I, Kester M, Koster E Blood. 2024; 143(18):1856-1872.

PMID: 38427583 PMC: 11076866. DOI: 10.1182/blood.2023022343.


Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells.

van Tienhoven R, Kracht M, van der Slik A, Thomaidou S, Wolters A, Giepmans B Diabetologia. 2023; 66(5):884-896.

PMID: 36884057 PMC: 10036285. DOI: 10.1007/s00125-023-05882-y.


The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes.

Roep B Front Immunol. 2023; 14:1112858.

PMID: 36733487 PMC: 9887285. DOI: 10.3389/fimmu.2023.1112858.


Epitope-based precision immunotherapy of Type 1 diabetes.

Firdessa Fite R, Bechi Genzano C, Mallone R, Creusot R Hum Vaccin Immunother. 2023; 19(1):2154098.

PMID: 36656048 PMC: 9980607. DOI: 10.1080/21645515.2022.2154098.


References
1.
Dogra R, Vaidyanathan P, Prabakar K, Marshall K, Hutton J, Pugliese A . Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia. 2006; 49(5):953-7. DOI: 10.1007/s00125-006-0185-8. View

2.
Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M . CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes. 2007; 56(3):613-21. DOI: 10.2337/db06-1419. View

3.
Gardner J, DeVoss J, Friedman R, Wong D, Tan Y, Zhou X . Deletional tolerance mediated by extrathymic Aire-expressing cells. Science. 2008; 321(5890):843-7. PMC: 2532844. DOI: 10.1126/science.1159407. View

4.
James E, Kwok W . Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes. Diabetes. 2008; 57(7):1788-9. PMC: 2453629. DOI: 10.2337/db08-0530. View

5.
Gorus F, Goubert P, Semakula C, Vandewalle C, De Schepper J, Scheen A . IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia. 1997; 40(1):95-9. DOI: 10.1007/s001250050648. View